ResMed Cash Provided by (Used in) Operating Activity, Including Discontinued Operation increased by 63.1% to $554.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.2%, from $578.66M to $554.13M. Over 4 years (FY 2021 to FY 2025), Cash Provided by (Used in) Operating Activity, Including Discontinued Operation shows an upward trend with a 24.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
A comprehensive measure of the company's total cash generation efficiency.
The consolidated net cash flow from operating activities, including both continuing and discontinued operations. It prov...
Standard consolidated cash flow metric used by all global enterprises.
other_net_cash_provided_by_used_in_operating_activities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $226.53M | -$65.66M | $219.88M | $117.44M | $79.49M | $44.66M | $128.64M | $282.57M | $237.44M | $286.28M | $272.83M | $402.03M | $440.11M | $325.54M | $308.62M | $578.66M | $538.77M | $457.32M | $339.75M | $554.13M |
| QoQ Change | — | -129.0% | +434.9% | -46.6% | -32.3% | -43.8% | +188.0% | +119.7% | -16.0% | +20.6% | -4.7% | +47.4% | +9.5% | -26.0% | -5.2% | +87.5% | -6.9% | -15.1% | -25.7% | +63.1% |
| YoY Change | — | — | — | — | -64.9% | +168.0% | -41.5% | +140.6% | +198.7% | +541.0% | +112.1% | +42.3% | +85.4% | +13.7% | +13.1% | +43.9% | +22.4% | +40.5% | +10.1% | -4.2% |